The estimated Net Worth of Michael Bavaro is at least 1.85 百万$ dollars as of 15 August 2024. Michael Bavaro owns over 5,765 units of Option Care Health stock worth over 1,595,329$ and over the last 2 years Michael sold OPCH stock worth over 256,307$.
Michael has made over 3 trades of the Option Care Health stock since 2023, according to the Form 4 filled with the SEC. Most recently Michael exercised 5,765 units of OPCH stock worth 143,721$ on 15 August 2024.
The largest trade Michael's ever made was selling 6,148 units of Option Care Health stock on 10 March 2023 worth over 193,355$. On average, Michael trades about 1,737 units every 65 days since 2023. As of 15 August 2024 Michael still owns at least 49,193 units of Option Care Health stock.
You can see the complete history of Michael Bavaro stock trades at the bottom of the page.
Michael's mailing address filed with the SEC is C/O OPTION CARE HEALTH, INC., 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN, IL, 60015.
Over the last 5 years, insiders at Option Care Health have traded over 6,426,460,535$ worth of Option Care Health stock and bought 202,320 units worth 5,246,552$ . The most active insiders traders include Timothy P Sullivan、Elizabeth Quadros Betten、Dearborn Partners Llcmadiso.... On average, Option Care Health executives and independent directors trade stock every 28 days with the average trade being worth of 157,254,886$. The most recent stock trade was executed by R Carter Pate on 3 September 2024, trading 1,465 units of OPCH stock currently worth 47,422$.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Option Care Health executives and other stock owners filed with the SEC include: